Pancreatic cancer drug response and resistance has been uncovered in unprecedented detail, thanks to a research tool developed at the Garvan Institute.
Apr 28, 2023
0
159
A unique treatment combining radiation and immunotherapy can eradicate pancreatic tumors while stopping the cancer from spreading, according to a new study by researchers at the University of Colorado Cancer Center.
Apr 27, 2023
0
80
Unintentional weight loss (UWL) is a common and serious problem, and according to several studies, it could be a sign—sometimes the only sign—of an underlying malignancy, such as a colorectal or pancreatic cancer.
Apr 26, 2023
0
2
Pancreatic ductal adenocarcinoma (PDAC) is the most common form of pancreatic cancer. It's also one of the deadliest. More than 90% of PDAC patients die within five years of diagnosis. Usually, by the time the cancer is identified, ...
Apr 26, 2023
0
0
The first-ever randomized clinical trial linked to registry data from the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) shows that for patients undergoing pancreatoduodenectomy, also ...
Apr 26, 2023
0
3
Pancreatic cancers are deadly and hard to treat, in part because they are so often detected at an advanced stage; overall five-year survival rates are about 11%. Two separate labs at Boston Children's Hospital took out-of-the-box ...
Apr 25, 2023
0
53
Researchers at the Johns Hopkins Kimmel Cancer Center identified a novel cell signaling pathway that potentially could be targeted in therapy for patients with aggressive pancreatic cancers.
Apr 24, 2023
0
32
Some 10% of cancers may be hereditary. And thanks to genetic testing, you can now determine your risk.
Apr 20, 2023
0
1
Researchers from The University of Texas MD Anderson Cancer Center presented promising findings from multiple clinical trials today at the American Association for Cancer Research (AACR) Annual Meeting 2023.
Apr 18, 2023
0
3
Among individuals who consented to whole-exome sequencing and were identified as carriers of predisposition genes for hereditary breast and ovarian cancer (HBOC) or Lynch syndrome, 39.2% would not have qualified for genetic ...
Apr 18, 2023
0
3
